Press-center

  • Labeling started. What is next? 01 July 2020

    Labeling started. What is next?

    From July 1, 2020, labeling of drugs becomes mandatory in Russia. However, no one gives guarantees of its uninterrupted operation, especially since the industry announced that it was not ready to start. The State Duma has prepared amendments to Federal Law No. 61 “On the Circulation of Medicines,” which should give the government the right to postpone the introduction of mandatory labeling of medicines in full. In the near future, they will be discussed in the third reading.

  • From July 1, marking starts in manual mode 09 June 2020

    From July 1, marking starts in manual mode

    Around the introduction of mandatory labeling of drugs in Russia there has been controversy for several years. Today the situation has escalated. There will be no postponing of start labeling. The inter-factional working group on improving the legislation in the field of drug provision recommended the Government a safe entry into the system from July 1. The Ministry of Health assured the deputies that there would be no problems with drug provision.

  • The pharmaceutical industry asked Vladimir Putin to postpone labeling start for 2021 02 June 2020

    The pharmaceutical industry asked Vladimir Putin to postpone labeling start for 2021

    11 pharmaceutical industry organizations uniting drug manufacturers, distributors, pharmacy organizations, the patient community wrote a collective letter addressed to President of the Russian Federation Vladimir Putin, in which draw attention of the head of state to the unpreparedness to launch industrial operation of the drug movement monitoring (DMM) system and give arguments why it is necessary to postpone the start scheduled for July 1, 2020.

  • Fifty days before the start or how to live after July 1? 11 May 2020

    Fifty days before the start or how to live after July 1?

    Labeling of drugs starts on July 1, or again, for objective reasons, the start will be postponed? The issue of postponing the start of drug labeling is particularly acute in a pandemic when the uninterrupted and timely provision of drugs to patients is crucial. The pharmaceutical industry, while supporting and understanding the importance of introducing a labeling system, also notes the risks associated with the launch of a system that is not 100% ready. The world situation associated with the threat of the spread of coronavirus has led to quarantine restrictions, which negatively affects the ability to start the system on time.

  • Let's try to solve something that is easy to solve 24 April 2020

    Let's try to solve something that is easy to solve

    In the created difficult conditions, it is impermissible luxury not to use and doom quality and safe medicines to spoilage. The law enforcement practice of suspension of circulation of drugs due to the identification of comments on production is such that the drug waits for the resumption of circulation in the warehouse until the identified comments are eliminated. Correction of comments is confirmed by repeated (control) inspection of production. Today, on-site inspection has become impossible due to quarantine restrictions. Accordingly, drugs deprived of circulation are waiting for the expiration date getting "dusty" in warehouses. Is it right and prudent? Of course not, especially since patients who interrupted therapy suffer from this.

  • 17 April 2020

    ARPM: there are no interruptions in drug supply and will not be

    To date, there is no interruption in medication and is not expected. We have sufficient reserves of drugs and raw materials, all the necessary reserves have been created. This was announced on April 16 by the director general of the Association of Russian Pharmaceutical Manufacturers Victor Dmitriev at the online conference of Kommersant Publishing House “Latest pharmaceutical industry news and anti-virus investments”.

  • Government Decree No. 500 is the victory of common sense 16 April 2020

    Government Decree No. 500 is the victory of common sense

    On April 13, Government Decree No. 500 was issued, which temporarily suspended the previously issued 431 Decree. The industry perceived this as a victory of common sense. As early as April 7, the Association of Russian Pharmaceutical Manufacturers contacted the Ministry of Industry and Trade for clarification on the enforcement of the Government Decree of April 3, No. 431 “On establishing the characteristics of the circulation of medical devices ...

  • Patent fight under the covers 14 April 2020

    Patent fight under the covers

    Generic manufacturers are against linking patent protection with drug registration procedure. Experts are sure, protecting the interests of one, barriers are created for other market participants. The legislative initiative will have a negative impact on both the Russian healthcare system and the pharmaceutical industry as a whole.

  • 09 April 2020

    ARPM: pharmaceutical industry mobilized to fight COVID-19

    Russia is doing everything possible to curb the spread of COVID-19. At this difficult time, the leading pharmaceutical companies unite and direct all their efforts to the creation and production of medicines and vaccines that everyone needs so much now. The pharmaceutical industry takes all necessary steps to maintain production continuity and ensure uninterrupted supply of medicines for patients both in Russia and the EAEU countries, and in countries that have applied for help to Russia.

  • Velfarm is a member of the Association of Russian Pharmaceutical Manufacturers 06 April 2020

    Velfarm is a member of the Association of Russian Pharmaceutical Manufacturers

    The Association of Russian pharmaceutical manufacturers is replenishing its ranks. In accordance with the decision of the ARPM general meeting, the company Velpharm LLC (BRIGHT WAY group of companies) became a new member. The company noted that they are optimistic about joining the ranks of the Association, which unites leading Russian pharmaceutical companies.
    Velfarm LLC is a Russian full-cycle pharmaceutical manufacturer that creates modern, effective, safe and affordable medicines.

  • 23 March 2020

    100 days before collapse

    Labeling of medicines is one of the most ambitious and discussed issues in the pharmaceutical industry. The entire pharmaceutical industry supports its introduction, but during the experiment, participants are faced with many problems that perplex not only the performers, but also the organizers of the project. In particular, manufacturers do not understand how to deal with a pandemic. Foreign specialists cannot come to production facilities for commissioning of the equipment, and Russian specialists cannot go abroad for testing and training. How do the experiment participants feel 100 days before the official launch of the drug labeling project?

  • Will coronavirus send labeling to quarantine? 19 March 2020

    Will coronavirus send labeling to quarantine?

    The Association of Russian Pharmaceutical Manufacturers sent a letter addressed to the Chairman of the State Duma of the Russian Federation Vyacheslav Volodin with a request to introduce a stop time for the period of restrictive quarantine measures for the introduction of drug labeling from July 1.
    Manufacturers contact the Association because of difficulties encountered in preparing for the launch of the mandatory drug labeling system.

  • ARPM: no need to escalate the situation 16 March 2020

    ARPM: no need to escalate the situation

    Prime Minister Mikhail Mishustin instructed to expedite the adoption of a bill that allows the remote sale of OTC (over-the-counter) drugs and their delivery due to an increase in the number of patients with coronavirus in the country. The State Duma may pass the law on selling drugs on the Internet on Thursday, March 19, Andrei Isaev, the first deputy head of the United Russia faction in the State Duma, announced this to REGNUM.

  • The common drug market in the EAEU is in the center of attention of pharmaceutical industry experts 12 March 2020

    The common drug market in the EAEU is in the center of attention of pharmaceutical industry experts

    “The functioning of the unified market for medicines of the Eurasian Economic Union” is the topic of a round table that will be held on April 7 as part of the XII scientific-practical conference “State regulation and the pharmaceutical industry”. The main issues of law enforcement requiring priority attention will be discussed by representatives of the EEC and authorized bodies of the countries of the Eurasian Economic Union with leading experts in the pharmaceutical industry.

  • We still have 116 days left ?! 05 March 2020

    We still have 116 days left ?!

    Starting March 1, all participants must be registered in the state drug movement monitoring (DMM) system. It is assumed that their information systems are already on alert for interaction with the state information system "DMM". To date, the most prepared link in the entire distribution chain are pharmaceutical manufacturers. But in the industry, there are still representatives of pharmacies and medical institutions who ask: what is labeling? Meanwhile, 116 days are left before the start. July 1, 2020 the law comes into force.

  • Interchangeability in Russia was, is and will be 02 March 2020

    Interchangeability in Russia was, is and will be

    The round table “Interchangeability of medicines” was held on the initiative of the Association of Russian Pharmaceutical Manufacturers in the press center of the publishing house “Komsomolskaya Pravda”. The discussion of the amendments adopted at the end of 2019 in 61-FL “On Circulation of Medicines” was joined by: the Federal Antimonopoly Service, the medical and patient communities, manufacturers and market experts. All parties have their own questions to the implementation of the rule of law.

  • 47 regions are on the track. Are “pilots” ready ?! 20 February 2020

    47 regions are on the track. Are “pilots” ready ?!

    Health issues come to the fore in the context of the goals and objectives of the development of our country. According to the order of the President of the Russian Federation Vladimir Putin, by July 1, 2020, the government needs to submit methodological proposals for a pilot project. Today, at the federal level, there is no understanding of how drug reimbursement models will be implemented. There are several suggestions, but there is no final decision as to which drug reimbursement system will be implemented, and there are no legal acts.

  • ARPM: 10 directions of pharmaceutical industry development 14 February 2020

    ARPM: 10 directions of pharmaceutical industry development

    February is the time to set goals for the coming year. The Director General of the Association of Russian Pharmaceutical Manufacturers Victor Dmitriev summed up the results of 2019, announced plans and dreams for 2020 at the meeting of the Russian Association of Pharmaceutical Marketing (RAPM). Welcoming the audience, the head of the ARPM noted that "it is impossible to change the past, but to draw conclusions, to analyze errors is simply necessary."

  • ARPM: are people behind the numbers or what is hidden behind the targets? 27 January 2020

    ARPM: are people behind the numbers or what is hidden behind the targets?

    In 2020, the national regime regarding the procurement of goods, work, services does not apply to products from the EAEU countries (Belarus, Kazakhstan, Armenia, Kyrgyzstan). Products from these states are not equivalent to foreign products under the national regime. These measures are designed to simplify and maintain the share of EAEU goods at the level of 50%. The government prepared the relevant amendments in 44-FL “On the contract system”. National regime includes preferences, restrictions and prohibitions. So, according to the new rules, it is forbidden to purchase foreign products for the defense and security of the country, but otherwise the “Third Extra” mechanism and price preferences will be applied.

  • "Regulatory guillotine" of alcohol-containing medicines was launched 21 January 2020

    "Regulatory guillotine" of alcohol-containing medicines was launched

    On January 17, a meeting of a working group from the expert and business community on the implementation of the “regulatory guillotine” in the production and turnover of alcoholic beverages took place. Ilya Lomakin-Rumyantsev, Director of the Center for Consumer Market Development at the Moscow School of Management Skolkovo, was elected Chairman of the working group. Olga Pentegova, Deputy Director General of the Association of Russian Pharmaceutical Manufacturers, represents the pharmaceutical industry.


News 1 - 20 from 208
First page | Prev. | 1 2 3 4 5 | Next | Last page